WebLandos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune disease. … WebAug 25, 2024 · Blade is advancing a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and multiple inhibitors of dimeric calpains designed for potential ...
Fighting fibrosis Nature Biotechnology
WebNov 8, 2024 · The combined company is expected to have a post-transaction enterprise value of approximately $352.8 million when it is finalized. Blade Therapeutics will … WebWe are positioned to build a pipeline across a range of fibrotic and neurodegenerative diseases. Learn More. Cudetaxestat. (Fibrosis) Phase 2. BLD-2184. … Blade Therapeutics is advancing a differentiated pipeline of oral, small … Blade Therapeutics is located at 442 Littlefield Avenue South San Francisco, … Press Releases and Articles for Blade Therapeutics. Blade is advancing … Blade Therapeutics is a biopharmaceutical company focused on developing cutting … Autotaxin/LPA and calpains each play distinct roles within the biological … Targeting Calpains in Fibrosis. Dimeric calpains (CAPNs 1, 2, 9) are calcium … Diseases characterized by uncontrolled, progressive fibrosis include idiopathic … references. Weber, 2014, Biomed Res Intl. 2014: 701758. Menzies, 2015, Cell … hon william rollo
Blade Therapeutics Announces Positive Data from ... - Business …
WebJan 3, 2024 · About Blade Therapeutics. ... small-molecule therapies that include a non-competitive autotaxin inhibitor and inhibitors of dimeric calpains designed for potential treatment of lung, liver and ... WebNov 30, 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Blade Therapeutics, Inc. (“Blade”), a biopharmaceutical company focused on developing cutting-edge treatments for debilitating fibrotic and neurodegenerative diseases, today announced positive topline data from a phase 1 drug-drug interaction clinical study of cudetaxestat, … WebMay 10, 2024 · Blade Therapeutics is focused on developing cutting-edge treatments for debilitating, incurable fibrotic and neurodegenerative diseases. The company has deep expertise in novel biological pathways – including autotaxin / LPA and calpain biology – that are foundational to cell- and tissue-damage responses associated with fibrotic and ... hon wok chinese food